Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 1355612-71-3, Caficrestat, At-001, Caficrestat [usan], E8i3o45ddu, 2-[5-oxo-6-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]pyrazino[2,3-d]pyridazin-8-yl]acetic acid
Molecular Formula
C17H10F3N5O3S
Molecular Weight
421.4  g/mol
InChI Key
YRGPAXAVTDMKDK-UHFFFAOYSA-N
FDA UNII
E8I3O45DDU

AT-001 is under investigation in clinical trial NCT03062384 (AT-001 for Long-term Preservation of Brain Health in Aging).
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[5-oxo-6-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]pyrazino[2,3-d]pyridazin-8-yl]acetic acid
2.1.2 InChI
InChI=1S/C17H10F3N5O3S/c18-17(19,20)8-1-2-11-9(5-8)23-12(29-11)7-25-16(28)15-14(21-3-4-22-15)10(24-25)6-13(26)27/h1-5H,6-7H2,(H,26,27)
2.1.3 InChI Key
YRGPAXAVTDMKDK-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC2=C(C=C1C(F)(F)F)N=C(S2)CN3C(=O)C4=NC=CN=C4C(=N3)CC(=O)O
2.2 Other Identifiers
2.2.1 UNII
E8I3O45DDU
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (8-oxo-7-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)-7,8- Dihydropyrazino(2,3-d)pyridazin-5-yl)acetic Acid

2. 7,8-dihydro-8-oxo-7-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)pyrazino(2,3-d)pyridazine-5-acetic Acid

3. At-001

4. At001

5. Caficrestat

2.3.2 Depositor-Supplied Synonyms

1. 1355612-71-3

2. Caficrestat

3. At-001

4. Caficrestat [usan]

5. E8i3o45ddu

6. 2-[5-oxo-6-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]pyrazino[2,3-d]pyridazin-8-yl]acetic Acid

7. 7,8-dihydro-8-oxo-7-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)pyrazino(2,3-d)pyridazine-5-acetic Acid

8. Pyrazino(2,3-d)pyridazine-5-acetic Acid, 7,8-dihydro-8-oxo-7-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-

9. Pyrazino[2,3-d]pyridazine-5-acetic Acid, 7,8-dihydro-8-oxo-7-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-

10. Caficrestat [inn]

11. Unii-e8i3o45ddu

12. Schembl359604

13. At 001 [who-dd]

14. Chembl4297455

15. Yrgpaxavtdmkdk-uhfffaoysa-n

16. At001

17. Ex-a4257

18. Who 11609

19. Akos030526447

20. Cs-5128

21. Db15121

22. Ncgc00484072-01

23. Hy-18967

24. Ms-27395

25. F85302

26. A927584

27. (8-oxo-7-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-7,8-dihydropyrazino[2,3-d]pyridazin-5-yl)acetic Acid

28. 2-(8-oxo-7-((5-(trifluoromethyl)benzo(d)thiazol-2-yl)methyl)-7,8-dihydropyrazino(2,3-d)pyridazin-5-yl) Acetic Acid

29. 2-(8-oxo-7-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-7,8-dihydropyrazino[2,3-d]pyridazin-5-yl)acetic Acid

2.4 Create Date
2012-02-27
3 Chemical and Physical Properties
Molecular Weight 421.4 g/mol
Molecular Formula C17H10F3N5O3S
XLogP32.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count11
Rotatable Bond Count4
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area137
Heavy Atom Count29
Formal Charge0
Complexity706
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1